XOMA Corporation (XOMAP) Financial Ratios
30 years of historical data (1995–2024) · Healthcare · Biotechnology
EV/EBITDA
↓
N/A
—
5yr avg: 15.41
30Y Low13.0·High17.8
P/FCF
N/A
—
5yr avg: 32.36
30Y Low32.4·High32.4
P/B Ratio
↑
3.68
↑+24% vs avg
5yr avg: 2.97
30Y Low2.3·High3.7
ROE
↓
-16.2%
↑-144% vs avg
5yr avg: -6.6%
30Y Low-390%·High252%
Debt/EBITDA
↓
N/A
—
5yr avg: 0.85
30Y Low0.0·High12.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
XOMA Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $317M | $303M | $291M | $283M | $321M | $287M | — | — | — | — | — |
| Enterprise Value | $335M | $320M | $263M | $225M | $228M | $224M | — | — | — | — | — |
| P/E Ratio → | -15.62 | — | — | — | 40.46 | 32.04 | — | — | — | — | — |
| P/S Ratio | 11.14 | 10.63 | 61.26 | 46.96 | 8.40 | 9.78 | — | — | — | — | — |
| P/B Ratio | 3.68 | 3.70 | 3.29 | 2.28 | 2.26 | 3.33 | — | — | — | — | — |
| P/FCF | — | — | — | — | — | 32.36 | — | — | — | — | — |
| P/OCF | — | — | — | — | 14.14 | 28.48 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 11.25 | 55.20 | 37.37 | 5.96 | 7.64 | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | 12.98 | 17.83 | — | — | — | — | — |
| EV / EBIT | — | — | — | — | 12.98 | 16.46 | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | 25.27 | — | — | — | — | — |
Profitability
Margins and return-on-capital ratios measuring operating efficiency
XOMA Corporation earns an operating margin of -140.3%. Operating margins have expanded from -288.9% to -140.3% over the past 3 years, signaling improving operational efficiency. A negative ROE of -16.2% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 99.3% | 99.3% | 97.0% | 95.5% | 99.6% | 99.4% | 93.2% | 68.3% | 85.1% | 74.8% | 62.7% |
| Operating Margin | -140.3% | -140.3% | -879.5% | -288.9% | 45.9% | 42.3% | -21.1% | -318.1% | 32.3% | -1106.4% | -71.6% |
| Net Profit Margin | -48.5% | -48.5% | -858.2% | -283.8% | 41.4% | 45.3% | -10.8% | -251.8% | 27.7% | -962.1% | -37.2% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -16.2% | -16.2% | -38.4% | -12.9% | 13.8% | 20.4% | -6.3% | -108.6% | 252.3% | — | -5216.7% |
| ROA | -6.1% | -6.1% | -21.8% | -11.1% | 10.8% | 12.0% | -2.5% | -24.5% | 39.7% | -103.4% | -25.1% |
| ROIC | -37.6% | -37.6% | -49.8% | -22.7% | 36.4% | 42.7% | -37.3% | — | — | — | — |
| ROCE | -19.4% | -19.4% | -24.0% | -12.1% | 13.2% | 12.4% | -5.4% | -35.3% | 101.1% | -257.8% | -75.9% |
Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $18M ($119M total debt minus $102M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.46 | 1.46 | 1.40 | 0.00 | 0.00 | 0.25 | 0.75 | 1.20 | 2.52 | — | — |
| Debt / EBITDA | — | — | — | — | 0.01 | 1.69 | — | — | 0.84 | — | — |
| Net Debt / Equity | — | 0.21 | -0.33 | -0.47 | -0.66 | -0.73 | -0.54 | -1.24 | -4.99 | — | — |
| Net Debt / EBITDA | — | — | — | — | -5.31 | -5.00 | — | — | -1.67 | — | — |
| Debt / FCF | — | — | — | — | — | -7.09 | — | — | -10.79 | — | — |
| Interest Coverage | -2.89 | -2.89 | -73.55 | — | 38.02 | 6.73 | -2.02 | -18.28 | 13.76 | -15.60 | -9.50 |
Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
XOMA Corporation's current ratio of 5.15x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 8.98x to 5.15x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.15 | 5.15 | 8.68 | 8.98 | 7.48 | 7.16 | 6.76 | 8.35 | 5.95 | 0.84 | 3.10 |
| Quick Ratio | 5.15 | 5.15 | 8.68 | 8.98 | 7.48 | 7.03 | 6.76 | 8.35 | 5.95 | 0.84 | 3.10 |
| Cash Ratio | 4.32 | 4.32 | 7.87 | 8.53 | 7.26 | 6.85 | 6.39 | 8.03 | 5.86 | 0.79 | 2.84 |
| Asset Turnover | — | 0.13 | 0.02 | 0.04 | 0.23 | 0.23 | 0.19 | 0.08 | 1.17 | 0.19 | 0.74 |
| Inventory Turnover | 0.11 | — | — | — | — | 0.11 | — | — | — | — | — |
| Days Sales Outstanding | — | 218.01 | 1167.49 | 143.35 | 2.00 | 22.22 | 58.28 | 101.12 | 2.75 | 37.13 | 26.79 |
Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
XOMA Corporation returns 1.8% to shareholders annually — split between a 1.8% dividend yield and 0.0% buyback yield.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.8% | 1.8% | 1.9% | 1.9% | 1.1% | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 2.5% | 3.1% | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | 3.1% | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Total Shareholder Yield | 1.8% | 1.8% | 1.9% | 1.9% | 1.1% | 0.0% | — | — | — | — | — |
| Shares Outstanding | — | $12M | $11M | $11M | $12M | $12M | $9M | $11M | $11M | $11M | $11M |
Peer Comparison
Compare XOMAP with 7 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 XOMAPYou | $317M | -15.6 | — | — | 99.3% | -140.3% | -16.2% | -37.6% | — |
 RPRX | $27B | 26.6 | 22.5 | 10.8 | — | 65.6% | 7.7% | 6.7% | 5.7 |
 LGND | $4B | -949.8 | 319.9 | 53.1 | 93.4% | -13.5% | -0.5% | -2.3% | 0.6 |
 INVA | $2B | 6.9 | 5.6 | 8.7 | 72.3% | 38.5% | 29.1% | 16.8% | — |
 BTX | $773M | 38.9 | 21.6 | 2.8 | 100.0% | 87.7% | 1.9% | 1.4% | — |
 XOMA | $316M | -16.0 | — | — | 99.3% | -140.3% | -16.2% | -37.6% | — |
 CBUS | $99M | -0.3 | — | — | 100.0% | -6062.8% | -115.3% | -86.2% | — |
 CDT | $1M | -0.0 | — | — | — | — | — | — | — |
| Healthcare Median | — | 23.2 | 14.9 | 19.0 | 65.8% | -6.4% | -36.7% | -13.6% | 3.0 |
Peers based on L4 peer group classification. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
See XOMAP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XOMAP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare XOMAP vs RPRX
See how XOMAP stacks up against sector leader Royalty Pharma plc.
Start ComparisonFrequently Asked Questions
What is XOMA Corporation's P/E ratio?
XOMA Corporation's current P/E ratio is -15.6x. The historical average is 36.3x.
What is XOMA Corporation's ROE?
XOMA Corporation's return on equity (ROE) is -16.2%. The historical average is -94.8%.
Is XOMAP stock overvalued?
Based on historical data, XOMA Corporation is trading at a P/E of -15.6x. Compare with industry peers and growth rates for a complete picture.
What is XOMA Corporation's dividend yield?
XOMA Corporation's current dividend yield is 1.81%.
What are XOMA Corporation's profit margins?
XOMA Corporation has 99.3% gross margin and -140.3% operating margin.